<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Jaskolski M</submitter><funding>Intramural NIH HHS</funding><funding>National Cancer Institute</funding><pagination>4059-66</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6310002</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>282(21)</volume><pubmed_abstract>Determinations of only a very few protein structures had consequences comparable to the impact exerted by the structure of the protease encoded by HIV-1, published just over 25 years ago. The structure of this relatively small protein and its cousins from other retroviruses provided a clear target for a spectacularly successful structure-assisted drug design effort that offered new hope for controlling the then-escalating AIDS epidemic. This reminiscence is limited primarily to work conducted at the National Cancer Institute, and is not meant to be a comprehensive history of the field, but is rather an attempt to provide a very personal account of how the structures of this most thoroughly studied crystallographic target were determined.</pubmed_abstract><journal>The FEBS journal</journal><pubmed_title>Elucidation of the structure of retroviral proteases: a reminiscence.</pubmed_title><pmcid>PMC6310002</pmcid><funding_grant_id>ZIA BC010348-15</funding_grant_id><pubmed_authors>Jaskolski M</pubmed_authors><pubmed_authors>Miller M</pubmed_authors><pubmed_authors>Wlodawer A</pubmed_authors><pubmed_authors>Mohana Rao JK</pubmed_authors><pubmed_authors>Gustchina A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Elucidation of the structure of retroviral proteases: a reminiscence.</name><description>Determinations of only a very few protein structures had consequences comparable to the impact exerted by the structure of the protease encoded by HIV-1, published just over 25 years ago. The structure of this relatively small protein and its cousins from other retroviruses provided a clear target for a spectacularly successful structure-assisted drug design effort that offered new hope for controlling the then-escalating AIDS epidemic. This reminiscence is limited primarily to work conducted at the National Cancer Institute, and is not meant to be a comprehensive history of the field, but is rather an attempt to provide a very personal account of how the structures of this most thoroughly studied crystallographic target were determined.</description><dates><release>2015-01-01T00:00:00Z</release><publication>2015 Nov</publication><modification>2024-11-08T22:57:13.344Z</modification><creation>2019-03-26T22:28:57Z</creation></dates><accession>S-EPMC6310002</accession><cross_references><pubmed>26258480</pubmed><doi>10.1111/febs.13397</doi></cross_references></HashMap>